StockClub

ATTBF

ATTBFAbattis Bioceuticals Corp.$ --
Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp.

ATTBF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2019FY2019 Q4
Revenue
0M CAD
YoY +9064.3%
Operating Income
-0M CAD
YoY -106.3%
Net Income
-1M CAD
YoY +98.3%
EPS
-0CAD
YoY +98.5%

Revenue

CAD356,876
FY2018 Q1CAD0
CAD0
Q1
FY2018 Q2CAD5,665
CAD5,665
Q2
FY2018 Q3CAD5,902
CAD5,902
Q3
FY2018 Q4CAD8,371
CAD8,371
Q4
FY2019 Q1CAD643
CAD643
Q1
FY2019 Q2CAD2,817
CAD2,817
Q2
FY2019 Q3CAD130,609
CAD130,609
Q3
FY2019 Q4CAD356,876
CAD356,876
Q4
Actual
+CAD348,505 (+4163.2%)

Net Income

CAD-3M
FY2018 Q1CAD-5.2M
CAD-5.2M
Q1
FY2018 Q2CAD-16.9M
CAD-16.9M
Q2
FY2018 Q3CAD-23.8M
CAD-23.8M
Q3
FY2018 Q4CAD-78M
CAD-78M
Q4
FY2019 Q1CAD-1.3M
CAD-1.3M
Q1
FY2019 Q2CAD-1.4M
CAD-1.4M
Q2
FY2019 Q3CAD-2.1M
CAD-2.1M
Q3
FY2019 Q4CAD-3M
CAD-3M
Q4
Actual
+CAD75M (+96.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2014
Actual:CAD7,720
FY2014
CAD7,720
FY2015
Actual:CAD91,940
FY2015
CAD91,940
FY2016
Actual:CAD0
FY2016
CAD0
FY2017
Actual:CAD0
FY2017
CAD0
FY2018
Actual:CAD8,371
FY2018
CAD8,371
FY2019
Actual:CAD356,876
FY2019
CAD356,876

Analyst Estimates

No forecast data